Bumper Offer - Urjas oil Just @ Rs. 1
Selca, a prescription drug, is manufactured in various forms such as Capsule. The alternative uses of Selca have also been explained below.
The optimal dosage of Selca is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Selca also has some side effects, the most common being Blurred vision, Cold hands. Some other side effects of Selca have been listed ahead. Usually, these side effects of Selca go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Selca's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Selca has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Selca related warnings section.
Individuals suffering from medical conditions like Diabetes, Low Blood Pressure (Hypotension), Asthma must refrain from the use of Selca since this can cause severe adverse effects. Some other conditions that can be affected by Selca are listed in the contraindications section below.
Drug reaction of Selca with other medicines has been reported. See below for a complete list.
You should also be aware that Selca is not safe while driving, and is not addiction.
Selca is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Selca is used -
Severe
Moderate
Mild
Common
Is the use of Selca safe for pregnant women?
Selca should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Selca safe during breastfeeding?
Selca may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Selca on the Kidneys?
Selca is not harmful for kidneys.
What is the effect of Selca on the Liver?
Selca has very mild side effects on the liver.
What is the effect of Selca on the Heart?
There is no research available on the side effects of Selca on the heart. Therefore, its impact is unknown.
Selca should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Selca unless your doctor advises you to do so -
Is this Selca habit forming or addictive?
No, there is no any evidence that Selca is addictive.
Interaction between Food and Selca
Some foods when eaten with Selca can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Selca
Due to lack of research, there is no information about the side effects of taking Selca with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Procardia XL® (nifedipine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 549
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 907-909
